Page 21 - Use Listing News Today

Bharat Biotech has been submitting data to WHO on a rolling basis and submitted additional information at WHOs request on September 27.

Europe is leading the way in lifting travel restrictions and reopening its borders, allowing fully vaccinated visitors in without having to quarantine thanks to successful COVID-19 vaccine rollouts.

The World Health Organization on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its COVID-19 shot, saying the WHO could not "cut corners" in making a decision.

WHO said, "we are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID-19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective."

Bharat Biotech, which developed Covaxin with an Indian state research body, started sharing data with the WHO from early July

The World Health Organisation yesterday asked for further data from India’s Bharat Biotech to consider the company’s request for an emergency-use listing for

BENGALURU (Reuters) -The World Health Organization on Monday asked for further data from Indias Bharat Biotech to consider the companys request for an emergency-use listing for its COVID-19 shot, saying

India's COVID-19 case load on declining side but caution needs to be observed: Task force head VK Paul

'Cannot cut corners': WHO expects 'one additional piece of information' from Bharat Biotech before recommending Covaxin

Bengaluru, October 18  The World Health Organisation on Monday asked for further data from India's Bharat Biotech to consider the company's request for an emergency-use listing for its Covid-19